The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.
www.marketwatch.com
#GSK #announces #billion #deal #targeting #onceperthreemonth #food #allergy #drug
GSK announces $2.2 billion deal, targeting once-per-three-month food allergy drug
